CFDE Data Portal | Search ARID4B

	Label	Description
	ARID4B Gene (Entity type)	ENSG00000054267 - AT-rich interaction domain 4B
	ARID4B associations Collection (Entity type)	Associations for ARID4B_associations
	ARID4B associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	ARID4B-IT1 associations Collection (Entity type)	Associations for ARID4B-IT1_associations
	ARID4B-IT1 associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	GSE144443 0 V 6 NICOTINAMIDE MOUSE UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE202434 GSE202438 talazoparib 6 v 11 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE229973 3 V 2 CISPLATIN HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE135350 3 V 5 DEXAMETHASONE HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE120612 4 V 1 ETOPOSIDE HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS

ARID4B

ENSG00000054267 - AT-rich interaction domain 4B

ARID4B associations

Associations for ARID4B_associations

ARID4B associations.tsv

A file from IDG as part of the Harmonizome project

ARID4B-IT1 associations

Associations for ARID4B-IT1_associations

ARID4B-IT1 associations.tsv

A file from IDG as part of the Harmonizome project

GSE144443 0 V 6 NICOTINAMIDE MOUSE UP

A Gene Set from LINCS

GSE202434 GSE202438 talazoparib 6 v 11 human up

A Gene Set from LINCS

GSE229973 3 V 2 CISPLATIN HUMAN DN

A Gene Set from LINCS

GSE135350 3 V 5 DEXAMETHASONE HUMAN UP

A Gene Set from LINCS

GSE120612 4 V 1 ETOPOSIDE HUMAN UP

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.